Facial Defect

Drug	Drug Name	Drug Description
DB08818	Hyaluronic acid	A glycosaminoglycan used for the relief of joint pain, wound healing, ophthalmologic treatment, cosmetic treatment, and various other applications.

Drug	Drug Name	Target	Type
DB08818	Hyaluronic acid	CD44 antigen	target
DB08818	Hyaluronic acid	Intercellular adhesion molecule 1	target
DB08818	Hyaluronic acid	Hyaluronan mediated motility receptor	target
DB08818	Hyaluronic acid	Neurocan core protein	target
DB08818	Hyaluronic acid	Versican core protein	target
DB08818	Hyaluronic acid	Complement component 1 Q subcomponent-binding protein, mitochondrial	target
DB08818	Hyaluronic acid	Hyaluronan and proteoglycan link protein 1	target
DB08818	Hyaluronic acid	Hyaluronan and proteoglycan link protein 3	target
DB08818	Hyaluronic acid	Hyaluronan-binding protein 2	target
DB08818	Hyaluronic acid	Layilin	target
DB08818	Hyaluronic acid	Stabilin-2	target
DB08818	Hyaluronic acid	Tumor necrosis factor-inducible gene 6 protein	target
DB08818	Hyaluronic acid	Interphotoreceptor matrix proteoglycan 2	target
DB08818	Hyaluronic acid	Intracellular hyaluronan-binding protein 4	target
DB08818	Hyaluronic acid	Hyaluronidase enzymes	enzyme
DB08818	Hyaluronic acid	Multidrug resistance-associated protein 5	transporter
DB08818	Hyaluronic acid	Lymphatic vessel endothelial hyaluronic acid receptor 1	target

Drug	Drug Name	Phase	Status	Count
DB00567	Cephalexin	4	Recruiting	1